NO20040353L - Ny terapeutsk metode - Google Patents

Ny terapeutsk metode

Info

Publication number
NO20040353L
NO20040353L NO20040353A NO20040353A NO20040353L NO 20040353 L NO20040353 L NO 20040353L NO 20040353 A NO20040353 A NO 20040353A NO 20040353 A NO20040353 A NO 20040353A NO 20040353 L NO20040353 L NO 20040353L
Authority
NO
Norway
Prior art keywords
therapeutic method
new therapeutic
new
therapeutic
Prior art date
Application number
NO20040353A
Other languages
English (en)
Norwegian (no)
Inventor
Richard Graham Knowles
Peter Ward
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20040353L publication Critical patent/NO20040353L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20040353A 2001-07-27 2004-01-26 Ny terapeutsk metode NO20040353L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118373.0A GB0118373D0 (en) 2001-07-27 2001-07-27 Novel therapeutic method
PCT/EP2002/008322 WO2003011274A2 (fr) 2001-07-27 2002-07-25 Methode therapeutique

Publications (1)

Publication Number Publication Date
NO20040353L true NO20040353L (no) 2004-03-26

Family

ID=9919332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040353A NO20040353L (no) 2001-07-27 2004-01-26 Ny terapeutsk metode

Country Status (18)

Country Link
US (1) US20040180918A1 (fr)
EP (1) EP1411914A2 (fr)
JP (1) JP2004538302A (fr)
KR (1) KR20040029384A (fr)
CN (1) CN1551763A (fr)
AR (1) AR034900A1 (fr)
BR (1) BR0211450A (fr)
CA (1) CA2455520A1 (fr)
CO (1) CO5550426A2 (fr)
GB (1) GB0118373D0 (fr)
HU (1) HUP0401614A2 (fr)
IL (1) IL160017A0 (fr)
MX (1) MXPA04000793A (fr)
NO (1) NO20040353L (fr)
PL (1) PL368585A1 (fr)
RU (1) RU2004105865A (fr)
WO (1) WO2003011274A2 (fr)
ZA (1) ZA200400410B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
CA2519682A1 (fr) * 2003-03-28 2004-10-07 Altana Pharma Ag Association synergique contenant du roflumilast et un agent anticholinergique selectionne parmi les sels d'ipratropium, d'oxitropium et de tiotropium et destinee au traitement de maladies respiratoires
WO2004084896A1 (fr) * 2003-03-28 2004-10-07 Altana Pharma Ag Association synergique
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1504756A1 (fr) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Compositions de médicaments contenant un composé hétérocyclique et un anticholinergique
ES2413011T3 (es) 2004-02-06 2013-07-15 Meda Pharma Gmbh & Co. Kg Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
EP1713471B1 (fr) * 2004-02-06 2012-01-18 MEDA Pharma GmbH & Co. KG Combinaison d'anticholinergiques et d'inhibiteurs de phosphodiesterase type 4 pour le traitement de maladies respiratoires
WO2005102344A1 (fr) * 2004-04-27 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. Composition pharmaceutique
EP1616567A1 (fr) * 2004-07-16 2006-01-18 Boehringer Ingelheim Pharma GmbH & Co.KG Médicaments comprenant des inhibiteurs de PDE-IV et des sels de glycopyrolate pour l'inhalation
EP1863476B1 (fr) 2005-03-16 2016-02-03 MEDA Pharma GmbH & Co. KG Combinaison d'anticholinergiques et d'antagonistes de recepteur de leukotriene permettant de traiter les maladies respiratoires
WO2006117299A2 (fr) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Formes cristallines de bromure de tiotropium
GB0521563D0 (en) 2005-10-21 2005-11-30 Glaxo Group Ltd Novel compounds
NZ591969A (en) 2005-12-21 2012-05-25 Meda Pharma Gmbh & Co Kg Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
PL2046787T3 (pl) 2006-08-01 2011-10-31 Glaxo Group Ltd Związki pirazolo[3,4-b]pirydynowe i ich zastosowanie jako inhibitory PDE4
KR20100014565A (ko) * 2007-04-11 2010-02-10 알콘 리서치, 리미티드 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 ｔｎｆａ의 억제제 및 항히스타민의 용도
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
US8470835B2 (en) 2009-01-13 2013-06-25 Glaxo Group Limited Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase
CN102548536A (zh) * 2009-10-01 2012-07-04 爱尔康研究有限公司 奥洛他定组合物及其用途
WO2012025474A1 (fr) 2010-08-24 2012-03-01 Glaxo Group Limited Composés indazole
WO2012025473A1 (fr) 2010-08-24 2012-03-01 Glaxo Group Limited Antagonistes du récepteur 4 des chimiokines cc
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
BR112015019276A2 (pt) 2013-02-19 2017-07-18 Pfizer compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
WO2016012896A1 (fr) 2014-07-24 2016-01-28 Pfizer Inc. Composés de pyrazolopyrimidine
MD20170011A2 (ro) 2014-08-06 2017-08-31 Pfizer Inc. Compuşi imidazopiridazinici

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
CZ20022410A3 (cs) * 2000-01-31 2003-08-13 Pfizer Products Inc. Benzoanelované heterocyklylové deriváty nikotinamidu užitečné jako selektivní inhibitory isozymů PDE4
DE60125026T2 (de) * 2000-03-23 2007-06-28 Takeda Pharmaceutical Co. Ltd. Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
AR029984A1 (es) * 2000-07-27 2003-07-23 Smithkline Beecham Corp Metodo para reducir las exacerbaciones asociadas copd ambito
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE60121813T2 (de) * 2000-12-28 2007-09-20 Almirall Ag Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten

Also Published As

Publication number Publication date
CA2455520A1 (fr) 2003-02-13
KR20040029384A (ko) 2004-04-06
IL160017A0 (en) 2004-06-20
GB0118373D0 (en) 2001-09-19
CN1551763A (zh) 2004-12-01
JP2004538302A (ja) 2004-12-24
AR034900A1 (es) 2004-03-24
BR0211450A (pt) 2004-07-20
WO2003011274A2 (fr) 2003-02-13
ZA200400410B (en) 2004-10-13
PL368585A1 (en) 2005-04-04
MXPA04000793A (es) 2004-05-21
WO2003011274A3 (fr) 2003-09-18
CO5550426A2 (es) 2005-08-31
HUP0401614A2 (hu) 2004-11-29
EP1411914A2 (fr) 2004-04-28
US20040180918A1 (en) 2004-09-16
RU2004105865A (ru) 2005-02-20

Similar Documents

Publication Publication Date Title
NO20040353L (no) Ny terapeutsk metode
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
NO20035156L (no) Fremgangsmåter for brønnbehandling
NO20035121D0 (no) Ny anvendelse
NO20033205D0 (no) Terapeutiske kromanforbindelser
NO20014597D0 (no) Fremgangsmåte
DE10197149T1 (de) Anti-Zusetz-Behandlungen
NO20043664L (no) Ny fremgangsmate
NO20033919D0 (no) Ny anvendelse
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE60208612D1 (de) Herzschrittmacher
FI20011252L (fi) Rakennusmenetelmä
SE0104471D0 (sv) New method
DE60229385D1 (de) Herzschrittmacher
SE0201055D0 (sv) New method
SE0103357D0 (sv) New method
SE0103416D0 (sv) New method
SE0103573D0 (sv) New method
SE0104227D0 (sv) New method
SE0102004D0 (sv) Indiviva-metoden
SE0100900D0 (sv) Method
DOP2001000312A (es) Metodo
SE0101479D0 (sv) Method
SE0100899D0 (sv) Method
FI20012580A0 (fi) Symmetrinen salausmenetelmä

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application